Jan 21 (Reuters) - Dyne Therapeutics Inc DYN.O:
DYNE THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR DYNE-101 FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1
DYNE THERAPEUTICS INC - TO SUBMIT FOR U.S. ACCELERATED APPROVAL IN H1 2026
Source text: ID:nGNX9m9Xf2
Further company coverage: DYN.O